AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
Episode 20. Management of Myeloma in LMICs
Blood Cancer Talks
The Problem With VRD Induction in the Public Setting
In most places they don't have access to PIs in the first line, even in the largest insurance government type coverage. They still don't use Bortezomide as a first line treatment. It's a big problem. We recently did a review of who are the editors of hematology journals and these are all journals from high income countries. So that means that most of the top science is for only the US, North America and Europe. You might argue that we should develop our own guidelines and our own data to guide our therapy. But do we have the research capacity to do that? Our guidelines are going to be of high quality. These are the kind of things I
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode